Le produit a bien été ajouté au panier.

discount label
Ac-KENALLRYLLDKDD-NH2
Vue en 3D

Biosynth logo

Ac-KENALLRYLLDKDD-NH2

Ref. 3D-PP42965

Taille indéfinieÀ demander
Livraison estimée en/au États-Unis, le mardi 10 décembre 2024

Informations sur le produit

Nom :
Ac-KENALLRYLLDKDD-NH2
Synonymes :
  • Ac-Lys-Glu-Asn-Ala-Leu-Leu-Arg-Tyr-Leu-Leu-Asp-Lys-Asp-Asp-amide
Description :

Peptide Ac-KENALLRYLLDKDD-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-KENALLRYLLDKDD-NH2 include the following: Structures and mechanism for the design of highly potent glucocorticoids Y He , W Yi , K Suino-Powell, XE Zhou, WD Tolbert - Cell research, 2014 - nature.comhttps://www.nature.com/articles/cr201452 Multidomain architecture of estrogen receptor reveals interfacial cross-talk between its DNA-binding and ligand-binding domains W Huang , Y Peng, J Kiselar , X Zhao - Nature , 2018 - nature.comhttps://www.nature.com/articles/s41467-018-06034-2 Agonist versus antagonist induce distinct thermodynamic modes of co-factor binding to the glucocorticoid receptor RR Kroe, MA Baker, MP Brown, NA Farrow - Biophysical , 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0301462207000816 Structural mechanisms in the regulation of the thyroid hormone receptor RL Wagner III - 1998 - search.proquest.comhttps://search.proquest.com/openview/94c3c2283cbf88102204e317c89b5089/1?pq-origsite=gscholar&cbl=18750&diss=y Inhibitors for Androgen Receptor Activation Surfaces RJ Fletterick , CALIFORNIA UNIV SAN FRANCISCO - 2007 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA462434 Relating Androgen Receptor Conformation to Function in Prostate Cancer Cells P Webb, CALIFORNIA UNIV SAN FRANCISCO - 2005 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA434610 An anti-TNF-glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases MJ McPherson, AD Hobson , A Hernandez Jr - Science Translational , 2024 - science.orghttps://www.science.org/doi/abs/10.1126/scitranslmed.add8936 Rational discovery of novel type-III FTF antagonists to competitively suppress TIF-2 coactivation in liver cancer L Xu, Z Chen, K Shao, Y Wang, L Cui - Journal of Receptors , 2019 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/10799893.2019.1690513 Structural basis of tropifexor as a potent and selective agonist of farnesoid X receptor L Jiang, D Xiao, Y Li, S Dai, L Qu, X Chen - Biochemical and , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X20319562 Conformational changes of the glucocorticoid receptor ligand binding domain induced by ligand and cofactor binding, and the location of cofactor binding sites L Frego, W Davidson - Protein science, 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1110/ps.051781406 Building transcriptional regulatory complexes: signals and surfaces KR Yamamoto, BD Darimont - Cold Spring Harbor , 1998 - symposium.cshlp.orghttps://symposium.cshlp.org/content/63/587.short Mechanisms that regulate androgen receptor transcriptional activity EB Askew - 2010 - cdr.lib.unc.eduhttps://cdr.lib.unc.edu/concern/dissertations/z316q268s Backbone 1H, 13C, and 15N resonance assignments of the ligand binding domain of the human wildtype glucocorticoid receptor and the F602S mutant variant C Köhler, G Carlström, S Taca¥ngefjord - Biomolecular NMR , 2018 - Springerhttps://link.springer.com/article/10.1007/s12104-018-9820-9 Dynamic allosteric communication pathway directing differential activation of the glucocorticoid receptor C Köhler, G Carlström, A Gunnarsson , U Weininger - Science , 2020 - science.orghttps://www.science.org/doi/abs/10.1126/sciadv.abb5277 Structure and specificity of nuclear receptor-coactivator interactions BD Darimont, RL Wagner, JW Apriletti - Genes & , 1998 - genesdev.cshlp.orghttps://genesdev.cshlp.org/content/12/21/3343.short Minimising the payload solvent exposed hydrophobic surface area optimises the antibody-drug conjugate properties AD Hobson , H Zhu, W Qiu, RA Judge - RSC Medicinal , 2024 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2024/md/d3md00540b

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP42965 Ac-KENALLRYLLDKDD-NH2

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".